Back to results
US 2022/0054595 A1Published application
Formulation Including a Combination of beta-Endorphin and Adrenocorticotropic Hormone
AssigneeAdamis Pharmaceuticals Corporation
InventorsCharles Peter Lollo, Dennis J. Carlo
Life of this patent
Estimating the term…
Abstract
The present specification provides compositions of β-endorphin and adrenocorticotropic hormone (ACTH). These compositions are useful in methods of treating disease.
Claims22
A pharmaceutical composition comprising, β-endorphin and adrenocorticotropic hormone (ACTH) or analogues thereof of either or both.
A pharmaceutical composition comprising, two active agents, wherein the active agents consist of β-endorphin and ACTH or analogues thereof.
(canceled)
Dependencies are inferred from the claim text.